Phibro Consolidates Manufacturing Network, Plans to Close Chicago Heights Plant

Dow Jones
Aug 27

Phibro Animal Health is shutting down its Chicago Heights, Ill., manufacturing facility as part of a strategic consolidation following its MFA acquisition in 2024. Production is expected to cease in summer 2027, affecting about 100 employees. The company says it conducted a comprehensive review of its manufacturing network to align its production footprint with current business needs. Manufacturing will transfer to other Phibro-owned facilities and select third-party contract manufacturers. CEO Dani Bendheim said the decision reflects a long-term effort to improve efficiency and strengthen competitiveness, not the performance of Chicago Heights employees.

 

This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors.

 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10